CPR Medical Negotiating Low-Voltage Defibrillation License With ICD Firm
This article was originally published in The Gray Sheet
Executive Summary
CPR Medical says it expects to finalize an agreement with a major implantable cardiac defibrillator (ICD) manufacturer in the next 30 days to license its proprietary low-voltage C-Fib defibrillation technology. Use of C-Fib could reduce ICD prices by more than 30% and ICD manufacturing costs by 50%, CPR maintains.